Actos Patients: Dosage Correlates with Risk
Actos (pioglitazone) is a dangerous drug for patients who take high doses over a long period of time, according to a multi-year analysis by the Food and Drug Administration (FDA). While the risk of Actos-induced bladder cancer is low at small cumulative dosage levels, there’s a significant spike in risk level for most Actos patients as they approach a year of taking regular Actos treatments.
What does this mean for Type 2 diabetes patients who rely on Actos to control blood sugar levels? For some, it means that the carcinogenic risks of Actos may outweigh its benefits.
The attorneys at Fears Nachawati are prepared to help you and your family sort out the medical, medicinal, legal, and financial challenges that you face as a result of the dangers of Actos. How can we help you? Find out today by giving us a call. For your free consultation, call us at 1.866.545.8364 or email email@example.com.